Calcipotriene NDC 0713-0318

NDC codes

FDA NDC Directory

Product NDC (as listed)0713-0318Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00713-0318Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0713-0318-53	00713031853	1 BOTTLE in 1 CARTON (0713-0318-53) / 60 mL in 1 BOTTLEMarketed from Mar 24, 2011

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcipotriene
Generic name (nonproprietary): calcipotriene
Active ingredients: Calcipotriene — .05 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Cosette Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078468
Marketing start: Mar 24, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Vitamin D (Chemical structure)
Identifiers: Product ID 0713-0318_ed81406a-8c10-5c33-e053-2a95a90a941fSPL ID ed81406a-8c10-5c33-e053-2a95a90a941fSPL set ID 21378c25-5622-8bf7-1a8c-b05940a846a0RxCUI 308865UNII 143NQ3779BUPC 0307130318532
Pharmacologic class: Vitamin D Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400713031853 followed by a unit qualifier and the quantity

Package 00713-0318-53. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 15, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Calcipotriene Topical Solution, 0.005% (Scalp Solution) is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078468

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078468
Product	Strength	Form · route	Labeler	Product NDC
Pellixcalcipotriene	Calcipotriene .05 mg/mL	SolutionTopical	Perfero Pharma, Inc.	87143-300